Organogenesis Holdings Inc (ORGO) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $3.70
• Market Cap: $521.61M
• EPS: $-0.08
• 52-Week High: $7.08
• 52-Week Low: $2.61

About Organogenesis Holdings Inc

Organogenesis Holdings Inc. (ORGO) is a prominent leader in regenerative medicine, dedicated to advancing patient care through its innovative allograft products and bioactive wound care therapies aimed at the advanced wound care, surgical, and sports medicine sectors in the United States. Based in Canton, Massachusetts, the company emphasizes scientific innovation and quality in its offerings, catering to the increasing demand for effective regenerative healthcare solutions. With a strong foc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Organogenesis Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ORGO pay dividends?

Organogenesis Holdings Inc (ORGO) does not currently pay a regular dividend.

What is ORGO's market cap?

Organogenesis Holdings Inc (ORGO) has a market capitalization of $521.61M with a current stock price of $3.70.